Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3593]

How to reinvigorate exhausted immune cells and stop cancer along the way

How to reinvigorate exhausted immune cells and stop cancer along the way

Researchers identify enzyme that suppresses immune system in breast cancer

Researchers identify enzyme that suppresses immune system in breast cancer

Cancer-killing virus boosts immunotherapy in hard-to-treat cancer

Cancer-killing virus boosts immunotherapy in hard-to-treat cancer

Antibody treatment allows transplant of mismatched stem cells, tissues in mice

Antibody treatment allows transplant of mismatched stem cells, tissues in mice

EHA 2019: Introduction of a new fixed-duration targeted therapy with venetoclax plus obinutuzumab in previously untreated patients with chronic lymphocytic leukaemia and coexisting comorbidities

EHA 2019: Introduction of a new fixed-duration targeted therapy with venetoclax plus obinutuzumab in previously...

Antibodies against HPV16 can develop up to 40 years before throat cancer is diagnosed

Antibodies against HPV16 can develop up to 40 years before throat cancer is diagnosed

FDA approves pembrolizumab for first-line treatment of head and neck squamous cell carcinoma

FDA approves pembrolizumab for first-line treatment of head and neck squamous cell carcinoma

Novel agent reactivates an immune call by LIF blockade

Novel agent reactivates an immune call by LIF blockade

Molecular chatter makes for a 'hot tumour'

Molecular chatter makes for a 'hot tumour'

FDA approves polatuzumab vedotin-piiq for diffuse large B-cell lymphoma

FDA approves polatuzumab vedotin-piiq for diffuse large B-cell lymphoma

More from ecancer